Skip to content

Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01989013
Enrollment
5
Registered
2013-11-20
Start date
2014-02-01
Completion date
2027-01-01
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's disease, Craniosacral therapy, cranial osteopathy

Brief summary

We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Detailed description

We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease

Interventions

OTHERbiweekly intervention

10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium

Sponsors

Zia, Al Raza
Lead SponsorINDIV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* must be Diagnosed with Parkinson's Disease

Exclusion criteria

* Anyone without Parkinson's Disease

Design outcomes

Primary

MeasureTime frameDescription
reduction in tremors due to Parkinson's disease in the patient3 monthsMeasurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction

Secondary

MeasureTime frameDescription
Quality of Proprioception3 monthswill evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAl Raza, CST

IBR, Inc.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026